- Home
- ATNM vs RBOT Comparison
ATNM vs RBOT Comparison
Compare ATNM & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- RBOT
- Stock Information
- Founded
- ATNM 2000
- RBOT 2014
- Country
- ATNM United States
- RBOT United States
- Employees
- ATNM N/A
- RBOT N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- RBOT Medical Specialities
- Sector
- ATNM Health Care
- RBOT Health Care
- Exchange
- ATNM Nasdaq
- RBOT Nasdaq
- Market Cap
- ATNM 51.5M
- RBOT 46.7M
- IPO Year
- ATNM N/A
- RBOT N/A
- Fundamental
- Price
- ATNM $1.47
- RBOT $7.61
- Analyst Decision
- ATNM Strong Buy
- RBOT Hold
- Analyst Count
- ATNM 3
- RBOT 2
- Target Price
- ATNM $4.67
- RBOT $9.25
- AVG Volume (30 Days)
- ATNM 518.4K
- RBOT 10.3K
- Earning Date
- ATNM 08-04-2025
- RBOT 08-11-2025
- Dividend Yield
- ATNM N/A
- RBOT N/A
- EPS Growth
- ATNM N/A
- RBOT N/A
- EPS
- ATNM N/A
- RBOT N/A
- Revenue
- ATNM N/A
- RBOT N/A
- Revenue This Year
- ATNM N/A
- RBOT N/A
- Revenue Next Year
- ATNM N/A
- RBOT N/A
- P/E Ratio
- ATNM N/A
- RBOT N/A
- Revenue Growth
- ATNM N/A
- RBOT N/A
- 52 Week Low
- ATNM $1.03
- RBOT $4.27
- 52 Week High
- ATNM $8.64
- RBOT $19.00
- Technical
- Relative Strength Index (RSI)
- ATNM 44.59
- RBOT 44.55
- Support Level
- ATNM $1.41
- RBOT $7.21
- Resistance Level
- ATNM $1.49
- RBOT $8.02
- Average True Range (ATR)
- ATNM 0.12
- RBOT 0.45
- MACD
- ATNM -0.02
- RBOT -0.08
- Stochastic Oscillator
- ATNM 25.00
- RBOT 19.05
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.